Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajiv K Bedi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Chemical Information and Modeling|October 19, 2020
Structural and Dynamic Insights into Redundant Function of YTHDF ProteinsYaozong Li, Rajiv K Bedi, Elena V Moroz-Omori, et al.
Chemmedchem|March 12, 2020
Small-Molecule Inhibitors of METTL3, the Major Human Epitranscriptomic WriterRajiv K Bedi, Danzhi Huang, Stefanie A Eberle, et al.
Scientific Reports|August 18, 2016
Understanding the structural basis of substrate recognition by Plasmodium falciparum plasmepsin V to aid in the design of potent inhibitorsRajiv K Bedi, Chandan Patel, Vandana Mishra, et al.
Journal of Medicinal Chemistry|August 25, 2021
1,4,9-Triazaspiro[5.5]undecan-2-one Derivatives as Potent and Selective METTL3 InhibitorsAymeric Dolbois, Rajiv K Bedi, Elena Bochenkova, et al.
Journal of Medicinal Chemistry|May 24, 2024
Structure-Based Design of a Potent and Selective YTHDC1 LigandFrantišek Zálešák, Francesco Nai, Marcin Herok, et al.
JACS Au|September 27, 2024
Structure-Based Design of CBP/EP300 Degraders: When Cooperativity Overcomes AffinityIván Cheng-Sánchez, Katherine Gosselé, Leonardo Palaferri, et al.
JACS Au|June 27, 2025
Selective CBP/EP300 Bromodomain Inhibitors: Novel Epigenetic Tools to Counter TNF-α-Driven InflammationKatherine A Gosselé, Irene Latino, Eleen Laul, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Chemical Information and Modeling|October 19, 2020
Structural and Dynamic Insights into Redundant Function of YTHDF ProteinsYaozong Li, Rajiv K Bedi, Elena V Moroz-Omori, et al.
Chemmedchem|March 12, 2020
Small-Molecule Inhibitors of METTL3, the Major Human Epitranscriptomic WriterRajiv K Bedi, Danzhi Huang, Stefanie A Eberle, et al.
Scientific Reports|August 18, 2016
Understanding the structural basis of substrate recognition by Plasmodium falciparum plasmepsin V to aid in the design of potent inhibitorsRajiv K Bedi, Chandan Patel, Vandana Mishra, et al.
Journal of Medicinal Chemistry|August 25, 2021
1,4,9-Triazaspiro[5.5]undecan-2-one Derivatives as Potent and Selective METTL3 InhibitorsAymeric Dolbois, Rajiv K Bedi, Elena Bochenkova, et al.
Journal of Medicinal Chemistry|May 24, 2024
Structure-Based Design of a Potent and Selective YTHDC1 LigandFrantišek Zálešák, Francesco Nai, Marcin Herok, et al.
JACS Au|September 27, 2024
Structure-Based Design of CBP/EP300 Degraders: When Cooperativity Overcomes AffinityIván Cheng-Sánchez, Katherine Gosselé, Leonardo Palaferri, et al.
JACS Au|June 27, 2025
Selective CBP/EP300 Bromodomain Inhibitors: Novel Epigenetic Tools to Counter TNF-α-Driven InflammationKatherine A Gosselé, Irene Latino, Eleen Laul, et al.
Pageof 1